{"mainPropery":{"diseaseId":10761,"diseaseName":"2-Hydroxyglutaric aciduria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10761/2-hydroxyglutaric-aciduria","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"ORPHANET","identifierId":"19"}]},"diseaseCategories":[{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":221,"resourceName":"Organic Acidemia Association","abbreviation":"","address1":"9040 Duluth Street","address2":"","address3":"","address4":"","address5":"","city":"Golden Valley","state":"MN","zip":"55427","country":"United States","phone":"763-559-1797","tty":"","tollFree":"","fax":"866-539-4060","email":"mkstagni@gmail.com","url":"http://www.oaanews.org/","freeText":""}],"resource descriptions":[{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/2-hydroxyglutaric-aciduria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on 2-Hydroxyglutaric aciduria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=19' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0050573' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9154,"questionText":"What is 2-hydroxyglutaric aciduria?","answerText":"<strong>2-hydroxyglutaric aciduria</strong> is a condition that causes progressive damage to the brain. The major types of this disorder are called D-2-hydroxyglutaric aciduria (D-2-HGA), L-2-hydroxyglutaric aciduria (L-2-HGA), and combined D,L-2-hydroxyglutaric aciduria (D,L-2-HGA). The main features of D-2-HGA vary within the different types but, in general, may&nbsp;include delayed development; seizures; weak muscle tone (hypotonia); and abnormalities in the largest part of the brain (the cerebrum), which controls many important functions such as muscle movement, speech, vision, thinking, emotion, and memory. The different types  and subtypes are caused by different <a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene </a><a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=\"_blank\">mutations</a> and are inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;pattern, except for a D-2HGA subtype, known as type II D-2-HGA, which is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;pattern.[9364] There is no cure yet. Treatment depends on the symptoms. Management mainly involves control of seizures when they are present.[13309]","dateModified":"2017-04-07T00:00:00"},"basicQuestions":[{"questionId":9156,"questionText":"How might 2-hydroxyglutaric aciduria be treated?","answerText":"There is still no established treatment.  However, for the D,L-2HGA type (combined type) some researches had used either malate or citrate. During malate treatment, urinary malate concentration increased, but beyond that, no effects were observed. In contrast, treatment with citrate led to some good results, but more studies are needed to confirm the effectiveness of this treatment.[9365]","dateModified":"2017-04-07T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9365,"authors":"MÃ¼hlhausen C, Salomons GS, Lukacs Z, Struys EA, van der Knaap MS, Ullrich K & Santer R","articleTitle":"Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"September, 2014","volume":"37(5)","pages":"775-81","url":"http://www.ncbi.nlm.nih.gov/pubmed/24687295","dateAccessed":"2015-07-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":5661,"relatedDiseaseName":"D-2-hydroxyglutaric aciduria","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10472,"relatedDiseaseName":"L-2-hydroxyglutaric aciduria","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"2-Hydroxyglutaric_aciduria"}